Published in Int J Cancer on September 24, 1999
Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol (2002) 1.25
The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev (2010) 1.13
Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol (2007) 1.04
BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer (2007) 1.01
Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol (2014) 1.00
The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol (2002) 0.89
Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker. Mol Cancer (2003) 0.85
BMP/SMAD signaling regulates the cell behaviors that drive the initial dorsal-specific regional morphogenesis of the otocyst. Dev Biol (2010) 0.84
Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion. Laryngoscope (2013) 0.81
Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview. Cancer Biol Med (2014) 0.79
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet (1993) 5.82
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med (1992) 5.51
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet (1994) 3.24
Community attitudes to cystic fibrosis carrier testing in England: a pilot study. Prenat Diagn (1989) 3.19
Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat Genet (1993) 3.04
Transport of macromolecules between the nucleus and the cytoplasm. RNA (1998) 2.63
Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J Med Genet (1992) 2.53
Carrier transport in two-dimensional graphene layers. Phys Rev Lett (2007) 2.52
Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res (1999) 2.51
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet (1992) 2.39
Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet (1994) 2.31
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res (1999) 2.21
Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol (2009) 2.11
Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy (2004) 2.07
Prognosis and treatment of disseminated uveal melanoma. Cancer (1993) 1.98
Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls. Clin Cancer Res (2001) 1.91
Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell (1997) 1.91
Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol (2007) 1.91
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol (1998) 1.77
Prospective comparison of endoscopic ultrasound-guided fine-needle aspiration and surgical histology in upper gastrointestinal submucosal tumors. Endoscopy (2010) 1.76
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Measurement of scattering rate and minimum conductivity in graphene. Phys Rev Lett (2007) 1.73
Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology (2001) 1.65
Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet (1993) 1.59
Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet (1994) 1.53
Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs (2007) 1.52
Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ (2002) 1.50
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45
Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells. Pancreas (1998) 1.45
Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem (1999) 1.43
A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma. J Cancer Res Clin Oncol (1998) 1.42
Propofol injection pain: is it still an issue? The effect of premedication. Minerva Anestesiol (2010) 1.42
[Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction]. Dtsch Med Wochenschr (2004) 1.42
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor. Bone Marrow Transplant (2003) 1.31
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer (2007) 1.27
Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol (2000) 1.25
Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet (1994) 1.25
Tuning the effective fine structure constant in graphene: opposing effects of dielectric screening on short- and long-range potential scattering. Phys Rev Lett (2008) 1.22
Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer (2006) 1.20
Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol (1998) 1.20
Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol (2006) 1.18
Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem (2001) 1.18
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Bone morphogenetic protein 4 (BMP-4), a member of the TGF-beta family, in early embryos of Xenopus laevis: analysis of mesoderm inducing activity. Mech Dev (1991) 1.16
Cardiovascular disease and hormone replacement treatment: a pilot case-control study. Br Med J (Clin Res Ed) (1981) 1.15
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol (1999) 1.13
Tiam1 mutations in human renal-cell carcinomas. Int J Cancer (2000) 1.12
Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia. J Cancer Res Clin Oncol (2001) 1.12
Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer (1997) 1.12
Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol (2000) 1.11
Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol (1997) 1.09
Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr Relat Cancer (2007) 1.08
Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol (2001) 1.08
Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature. Int J Colorectal Dis (2003) 1.07
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol (2004) 1.06
Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am J Pathol (1993) 1.06
Risk reversals in predictive testing for Huntington disease. Am J Hum Genet (1997) 1.06
Commitment to differentiation of human promyelocytic leukemia cells (HL60): an all-or-none event preceded by reversible losses of self-renewal potential. J Cell Physiol (1985) 1.04
Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas. Br J Cancer (2004) 1.04
Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol (2003) 1.04
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays. J Cancer Res Clin Oncol (2008) 1.03
NMR, CD and IR spectroscopies of a tridecanucleotide containing a no-base residue: coexistence of B and Z conformations. Nucleic Acids Res (1986) 1.01
p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer (1994) 1.01
Left-handed helical structure of poly[d(A-C)].poly[d(G-T)] studied by infrared spectroscopy. Biochemistry (1984) 1.01
Interaction of transition metal ions with Z form poly d(A-C).poly d(G-T) and poly d(A-T) studied by I.R. spectroscopy. Nucleic Acids Res (1986) 1.00
Molecular characterization of breast cancer cell lines by expression profiling. J Cancer Res Clin Oncol (2002) 1.00
Incidental findings from clinical genome-wide sequencing: a review. J Genet Couns (2013) 0.99
Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine. J Cancer Res Clin Oncol (2001) 0.99
The B----Z transition in two synthetic oligonucleotides: d(C-2-amino-ACGTG) and d(m5CGCAm5CGTGCG) studied by IR, NMR and CD spectroscopies. Nucleic Acids Res (1984) 0.99
Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res (1998) 0.99
Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus. J Cancer Res Clin Oncol (1999) 0.99
Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis. Cancer (1998) 0.98
Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol (2005) 0.97
Incidence and prognostic significance of vascular and neural invasion in squamous cell carcinomas of the esophagus. Int J Cancer (1995) 0.97
Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth. Int J Cancer (1978) 0.97
Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells. J Cancer Res Clin Oncol (2006) 0.97
Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer (1999) 0.97
Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett's) adenocarcinomas. Dis Esophagus (2007) 0.96
The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma. Int J Cancer (2006) 0.96
Analysis of growth factor-dependent signalling in human epithelioid sarcoma cell lines. clues To the role of autocrine, juxtacrine and paracrine interactions in epithelioid sarcoma. Eur J Cancer (2000) 0.96
Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res (1996) 0.95
Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men. J Nutr (2000) 0.95
Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res (2005) 0.95
[Chemotherapy of malignant bone tumors]. Chirurg (1977) 0.95
Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene (1994) 0.95
The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors. J Biol Chem (1998) 0.95
Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia. Leuk Res (2007) 0.95
Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan. Cell Death Differ (2000) 0.95
Simultaneous detection of ubiquinol-10, ubiquinone-10, and tocopherols in human plasma microsamples and macrosamples as a marker of oxidative damage in neonates and infants. Anal Biochem (2000) 0.94
Letter: Chromosome abnormalities in angioimmunoblastic lymphadenopathy. Lancet (1976) 0.93
Squamous cell carcinoma and Zenker diverticulum. Dis Esophagus (2007) 0.93
Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. Am J Pathol (1999) 0.93
Achalasia-associated squamous cell carcinoma of the esophagus: flow-cytometric and histological evaluation. Gastroenterology (1995) 0.93
Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol Pharmacol (1998) 0.93
Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol (2007) 0.92